10 Cellvizio-related abstracts, including landmark multicenter pancreatic cyst data, AI-driven IBD assessment, and new food intolerance applications, reinforce the breadth and depth of real-time cellular imaging
CLIMB Study to be presented at ASGE Presidential Plenary Session on Sunday, May 3, 2026 by Principal Investigator Dr. Som Krishna, The Ohio State University Wexner Medical Center
Paris and Boston, April 28, 2026 – 5:45 p.m. CEST – Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today highlights its extensive clinical presence at the upcoming 2026 Digestive Disease Week® (DDW), taking place May 2-5 at McCormick Place in Chicago, Illinois. Ten Cellvizio-related abstracts accepted by DDW 2026 span four of the most clinically and commercially important areas the Company is pursuing: pancreatic cystic lesions, early detection of gastric cancer, AI-assisted inflammatory bowel disease (IBD) assessment, and food intolerance diagnosis.
“DDW 2026 is a pivotal moment for Cellvizio. The scale, methodological rigor, independence, and geographic breadth of the work being presented this year, including the largest multicenter EUS-nCLE studies ever conducted in pancreatic cysts, confirm Cellvizio’s importance in the key clinical and commercial indications we are pursuing,” said Sacha Loiseau, Ph.D., Chairman and CEO of Mauna Kea Technologies. “Beyond the presentations and posters, our footprint at DDW 2026 reflects an increased level of clinical and commercial momentum on the ground. We are proud to support our largest-ever Pancreatic Cyst Consortium Meeting, organized by The Ohio State University, which will gather more than one hundred interventional endoscopists around the integration of needle-based endomicroscopy into diagnostic algorithms; to host a dedicated CellTolerance® dinner with U.S. and European key opinion leaders advancing our food intolerance program; and to be present at our partner TaeWoong Medical USA’s booth, reinforcing the joint commercial dynamic we are building in the United States.”
An indicative list of abstracts to be presented, grouped by indication, is provided below1:
Pancreatic Cystic Lesions:
The CLIMB study (Confocal Laser Endomicroscopy as an IMaging Biomarker, ClinicalTrials.gov ID: NCT03492151) will be presented at the ASGE (American Society for Gastrointestinal Endoscopy) Presidential Plenary Session entitled Innovation, Education, Practice Prevention – Past, Present and Future at 3:52pm on Sunday, May 3, 2026, one of the most prestigious sessions of the DDW 2026 conference.
1. How Can You Identify Cysts That Need Therapy, Going Above and Beyond Cyst Fluid Analysis – Endomicroscopy or Biopsy
Krishna et al. – Oral presentation #Sp184, Saturday, May 2, 10:03am
2. Multicenter Prospective Study of EUS-nCLE For Multimodal Diagnosis of Pancreatic Cystic Lesions (n=526)
Serrao, Krishna et al. – Oral presentation #859, Monday, May 4, 2:00pm
3. Reduction of Inappropriate Resections of Pancreatic Cystic Lesions (PCLs) Through Adoption of Multimodal Diagnostics
Krishna et al. – Oral presentation #856, Monday, May 4, 2:06pm
4. Pancreatic Cysts: New Insights and Novel Concepts
Krishna et al. – Oral presentation #Sp871, Monday, May 4, 3:12pm
5. Real-Time Endoscopic Diagnosis of Pancreatic Serous Cystadenomas Using EUS-nCLE
Park, Krishna et al. – Oral presentation #860, Monday, May 4, 3:24pm
Artificial Intelligence and IBD / Food Intolerance:
6. AI-Driven Automated Assessment of Intestinal Barrier Impairment in IBD
Iacucci et al. – Poster presentation Tu1491, Tuesday, May 5, 12:30pm
7. Confocal Laser Endomicroscopy Identifies Corn as a Common Source of Mucosal Immune Reactivity
Sirimongkolkasem, Spencer, Nguyen et al. – Poster presentation Tu1781, Tuesday, May 5, 12:30pm
8. Glucose/Lactulose Breath Test Does Not Predict Food Antigen Reactivity Assessed by Confocal Laser Endomicroscopy (CLE)
Karhu, Spencer, Nguyen et al. – Poster presentation Su1308, Sunday, May 3, 12:30pm
Gastric Lesions:
9. Establishment and Evaluation of a pCLE Training System in the Diagnosis of Gastric Cancerous Lesions
Pan, Liao et al. – Poster presentation Mo1086, Monday, May 4, 12:30pm
10. A Practical CLE Scoring Tool for Gastric Intestinal Metaplasia
Bains, Melson et al. – Poster presentation Tu1232, Tuesday, May 5, 12:30pm
1 all times are local Chicago time (CDT)
